How do you pay?

How to pay the least

Cash price

$5,910+ for 30 tablets

Pharmacies pay about this for Cibinqo; you’d pay more.

  1. Ask your pharmacy for Cibinqo’s cash price, and one or two other pharmacies too.
  2. Cibinqo’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Pfizer Patient Assistance Program. Meet the income requirements – Your annual household pre-tax income cannot exceed 300% of the Federal Poverty Level, adjusted for household size. Or call 1-844-989-7284.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameCibinqo
Authorized genericabrocitinib
Regular genericabrocitinib
What you’d pay
At least$5,910for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Cibinqo?
The original
–
–

Brand nameThe maker’s card

Pfizer Dermatology Patient Access Copay Savings Card

Savings card from Pfizer

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $4,000–$15,000 a year off your co-pay.

Sign up on cibinqo.com 

Or call 1-833-956-3376.

In the maker’s words

“By using this copay card at participating pharmacies, eligible patients with commercial prescription drug insurance coverage for CIBINQO® (abrocitinib) may pay as little as $0 per month.”

From the maker’s offer on cibinqo.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Cibinqo itself, from the same company, sold without the brand name, and usually for less. For now Cibinqo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

CIBINQO is a Janus kinase (JAK) inhibitor indicated for the treatment of adults and pediatric patients 12 years of age and older with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable. Limitation of Use: CIBINQO is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, or with other immunosuppressants.

Source: the FDA label for Cibinqo (Pfizer Laboratories Div Pfizer Inc), September 9, 2026. Full label on DailyMed 

Good to know